The administration released an executive order to significantly reduce the federal workforce. Together with other executive actions to date, cancer research and innovation are at risk.
The Senate Budget Committee is scheduled to mark up its budget resolution this week, setting the stage for significant cuts in discretionary spending to offset the cost of the package.
A bill introduced in the House and Senate last week aims to improve future equitable access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more individuals.
Bipartisan legislation that would remove financial barriers to prostate cancer screening was introduced today in the U.S. Senate. Sponsored by Senators John Boozman (R-AR) and Cory Booker (D-NJ), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements such as deductibles, copayments and coinsurance, for prostate cancer screening tests for men with the highest risk of prostate cancer, including Black men and those with a family history of the disease.
Eighty-six percent of cancer patients and survivors who receive tax credits to afford Marketplace plans say they would have difficulty getting the care they need without the enhanced premium tax credits, according to the latest Survivor Views survey from ACS CAN.
Washington, D.C. – Today, patient groups representing millions of individuals with serious diseases and health conditions submitted an amicus curiae (friend of the court) brief urging the U.S. Court of Appeals for the Eighth Circuit to uphold insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients, as permitted by the Department of Health and Human Services (HHS) Final Rule issued in May 2024.
Today, the United States Food and Drug Administration (FDA) released a proposed rule to reduce nicotine levels in cigarettes and certain other combusted tobacco products to minimally additive or nonaddictive levels.
Today, the U.S. Food and Drug Administration (FDA) released a proposed rule on front-of-package (FOP) nutrition labels, that would mandate a nutrition information box on the front of food packages to complement the existing required Nutrition Facts label.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023.